April 24, 2026
FAVLYXA™ now available
FAVLYXA™ (fluorouracil) is a nucleoside metabolic inhibitor indicated for the treatment of patients with:
- Adenocarcinoma of the Colon and Rectum
- Adenocarcinoma of the Breast
- Gastric Adenocarcinoma
- Pancreatic Adenocarcinoma
Please see full prescribing information here.
